Development of a Novel Assay to Assess the Avidity of Dengue Virus-Specific Antibodies Elicited in Response to a Tetravalent Dengue Vaccine
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Development of a Novel Assay to Assess the Avidity of Dengue Virus-Specific Antibodies Elicited in Response to a Tetravalent Dengue Vaccine
Authors
Keywords
-
Journal
JOURNAL OF INFECTIOUS DISEASES
Volume -, Issue -, Pages -
Publisher
Oxford University Press (OUP)
Online
2021-01-29
DOI
10.1093/infdis/jiab064
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Differential human antibody repertoires following Zika infection and the implications for serodiagnostics and disease outcome
- (2019) Supriya Ravichandran et al. Nature Communications
- Repeat vaccination reduces antibody affinity maturation across different influenza vaccine platforms in humans
- (2019) Surender Khurana et al. Nature Communications
- Qualified Biolayer Interferometry Avidity Measurements Distinguish the Heterogeneity of Antibody Interactions withPlasmodium falciparumCircumsporozoite Protein Antigens
- (2018) S. Moses Dennison et al. JOURNAL OF IMMUNOLOGY
- Dengue virus-like particles mimic the antigenic properties of the infectious dengue virus envelope
- (2018) Stefan W. Metz et al. Virology Journal
- The immune response against flaviviruses
- (2018) Jose Luis Slon Campos et al. NATURE IMMUNOLOGY
- Safety and immunogenicity of one versus two doses of Takeda's tetravalent dengue vaccine in children in Asia and Latin America: interim results from a phase 2, randomised, placebo-controlled study
- (2017) Xavier Sáez-Llorens et al. LANCET INFECTIOUS DISEASES
- The development of therapeutic antibodies against dengue virus
- (2016) Guntur Fibriansah et al. ANTIVIRAL RESEARCH
- How to assess the binding strength of antibodies elicited by vaccination against HIV and other viruses
- (2016) P. J. Klasse Expert Review of Vaccines
- An elaborate landscape of the human antibody repertoire against enterovirus 71 infection is revealed by phage display screening and deep sequencing
- (2016) Zhe Chen et al. mAbs
- Initiation of immune tolerance–controlled HIV gp41 neutralizing B cell lineages
- (2016) Ruijun Zhang et al. Science Translational Medicine
- Evaluation of potential immunogenicity differences betweenPandemrix™ andArepanrix™
- (2016) Quentin Canelle et al. Human Vaccines & Immunotherapeutics
- Nasal Immunization Confers High Avidity Neutralizing Antibody Response and Immunity to Primary and Recurrent Genital Herpes in Guinea Pigs
- (2016) Josefine Persson et al. Frontiers in Immunology
- Antibody avidity following secondary dengue virus type 2 infection across a range of disease severity
- (2015) Louis Lau et al. JOURNAL OF CLINICAL VIROLOGY
- Safety and Immunogenicity of a Tetravalent Dengue Vaccine Candidate in Healthy Children and Adults in Dengue-Endemic Regions: A Randomized, Placebo-Controlled Phase 2 Study
- (2015) Chukiat Sirivichayakul et al. JOURNAL OF INFECTIOUS DISEASES
- A highly potent human antibody neutralizes dengue virus serotype 3 by binding across three surface proteins
- (2015) Guntur Fibriansah et al. Nature Communications
- Strategies to guide the antibody affinity maturation process
- (2015) Nicole A Doria-Rose et al. Current Opinion in Virology
- Single-Cell and Deep Sequencing of IgG-Switched Macaque B Cells Reveal a Diverse Ig Repertoire following Immunization
- (2014) C. Sundling et al. JOURNAL OF IMMUNOLOGY
- Safety and immunogenicity of a recombinant live attenuated tetravalent dengue vaccine (DENVax) in flavivirus-naive healthy adults in Colombia: a randomised, placebo-controlled, phase 1 study
- (2014) Jorge E Osorio et al. LANCET INFECTIOUS DISEASES
- Rapid development of broadly influenza neutralizing antibodies through redundant mutations
- (2014) Leontios Pappas et al. NATURE
- Antibody avidity measurements in recipients of Cervarix® vaccine following a two-dose schedule or a three-dose schedule
- (2014) Mathieu Boxus et al. VACCINE
- Surface plasmon resonance measurements of plasma antibody avidity during primary and secondary responses to anthrax protective antigen
- (2013) Heather E. Lynch et al. JOURNAL OF IMMUNOLOGICAL METHODS
- Functional Analysis of Antibodies against Dengue Virus Type 4 Reveals Strain-Dependent Epitope Exposure That Impacts Neutralization and Protection
- (2013) S. Sukupolvi-Petty et al. JOURNAL OF VIROLOGY
- High-Avidity and Potently Neutralizing Cross-Reactive Human Monoclonal Antibodies Derived from Secondary Dengue Virus Infection
- (2013) Wen-Yang Tsai et al. JOURNAL OF VIROLOGY
- The global distribution and burden of dengue
- (2013) Samir Bhatt et al. NATURE
- The Potent and Broadly Neutralizing Human Dengue Virus-Specific Monoclonal Antibody 1C19 Reveals a Unique Cross-Reactive Epitope on the bc Loop of Domain II of the Envelope Protein
- (2013) S. A. Smith et al. mBio
- Correlation between Dengue-Specific Neutralizing Antibodies and Serum Avidity in Primary and Secondary Dengue Virus 3 Natural Infections in Humans
- (2013) Andreas Puschnik et al. PLoS Neglected Tropical Diseases
- Germinal Centers
- (2012) Gabriel D. Victora et al. Annual Review of Immunology
- Practical quantitative and kinetic applications of bio-layer interferometry for toxicokinetic analysis of a monoclonal antibody therapeutic
- (2012) Mark Dysinger et al. JOURNAL OF IMMUNOLOGICAL METHODS
- Identification of human neutralizing antibodies that bind to complex epitopes on dengue virions
- (2012) R. de Alwis et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The Structural Basis for Serotype-Specific Neutralization of Dengue Virus by a Human Antibody
- (2012) E. P. Teoh et al. Science Translational Medicine
- The Development of Therapeutic Antibodies That Neutralize Homologous and Heterologous Genotypes of Dengue Virus Type 1
- (2010) Bimmi Shrestha et al. PLoS Pathogens
- Broad and Potent Neutralizing Antibodies from an African Donor Reveal a New HIV-1 Vaccine Target
- (2009) L. M. Walker et al. SCIENCE
- Rapid cloning of high-affinity human monoclonal antibodies against influenza virus
- (2008) Jens Wrammert et al. NATURE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now